Why MAC clauses are no Covid-19 silver bullet
IFLR is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Cookies Settings

Why MAC clauses are no Covid-19 silver bullet

Karry Lai
March 25, 2020
boss-umbrella.jpeg

Private equity and M&A experts expect to see buyers introducing material adverse change clauses into negotiations, but precision is key in drafting

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login

Topics

CorporateNews analysisM&AIFLR MagazineSpring 2020Hong Kong SARChina PRC
karry-lai-300px.png
Karry Lai
Managing editor
Contact
Karry is managing editor of IFLR. She manages the team and is responsible for IFLR's content. She also sits on the editorial judging panels of IFLR's global awards and the Women in Business Law Awards. Before joining the legal media industry, she was project manager at a startup focused on sustainable lifestyle media and events.